75 completed, 9 unknown, 3 terminated, 1 recruiting. 88 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 88 | Completed 75, Unknown 9, Terminated 3, Recruiting 1 |
| Phase 2 | 6 | Completed 4, Unknown 2 |
Follow Esomeprazole: new trials by email Literature Review of Esomeprazole trials Research Report on Esomeprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug Interaction Study on Linaprazan Glurate Capsules Linaprazan Glurate Capsules, Bismuth Potassium Citrate Capsules, Amoxicillin Capsules - Healthy Volunteers, Patients | Phase 1 | Completed | Jiangsu Sinorda Biomedicine Co., Ltd | 56 | 2025-09-08 | 2026-01-06 |
| A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants INCB161734, Itraconazole, Rifampin - Healthy Participants | Phase 1 | Completed | Incyte Corporation | 63 | 2025-07-16 | 2025-11-26 |
| A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults Zasocitinib, COC, Metformin - Healthy Volunteers | Phase 1 | Completed | Takeda | 78 | 2025-01-23 | 2025-04-04 |
| Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination Ledaborbactam etzadroxil, Ceftibuten, Ceftibuten-ledaborbactam etzadroxil - Healthy Volunteer, Pharmacokinetics | Phase 1 | Recruiting | Basilea Pharmaceutica | 96 | 2025-01-07 | 2026-11-05 |
| A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers NX-5948, Esomeprazole, Placebo - Healthy Volunteer | Phase 1 | Completed | Nurix Therapeutics, Inc. | 223 | 2024-11-30 | 2026-07-28 |
| A Phase I Study of LX22001 for Injection in Healthy Subjects LX22001 for Injeciton, Tegoprazan tablet, Esomeprazole sodium for injection - Healthy | Phase 1 | Completed | Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. | 100 | 2024-08-05 | 2026-11-19 |
| Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis Esomeprazole, Placebo - Fatty Liver Disease, Steatohepatitis, Nonalcoholic | Phase 1 / Phase 2 | Unknown | Sadat City University | 46 | 2024-06-01 | 2024-05-22 |
| A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood BI 300202, esomeprazole - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 15 | 2024-05-22 | 2025-01-22 |
| A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants Emraclidine, Esomeprazole - Healthy Participants | Phase 1 | Completed | Cerevel Therapeutics, LLC | 20 | 2024-05-10 | 2024-07-24 |
| A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants BAY2927088, Esomeprazole, Food - Advanced Non-small Cell Lung Cancer, EGFR Mutation | Phase 1 | Completed | Bayer | 21 | 2024-03-29 | 2024-07-05 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant INCB160058, Placebo, Esomeprazole - Healthy Participants | Phase 1 | Completed | Incyte Corporation | 137 | 2024-03-14 | 2025-10-14 |
| A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant vepdegestrant, esomeprazole - Healthy | Phase 1 | Completed | Pfizer | 12 | 2024-02-23 | 2024-06-03 |
| A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood Avenciguat (BI 685509) (intended commercial formulation (iCF)), Avenciguat (BI 685509) (trial formulation 2 (TF2)), esomeprazole - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 16 | 2024-01-16 | 2024-03-20 |
| Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects Clopidogrel 75 mg, Tegoprazan 25 mg, Esomeprazole 20mg - Healthy | Phase 1 | Unknown | HK inno.N Corporation | 48 | 2023-12-05 | 2023-12-11 |
| A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B UCB0599, Esomeprazole, Placebo - Healthy Study Participants | Phase 1 | Completed | UCB Biopharma SRL | 73 | 2023-05-31 | 2025-12-22 |
| A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants Brensocatib, Rifampin, Esomeprazole - Healthy Volunteers | Phase 1 | Completed | Insmed Incorporated | 32 | 2023-05-10 | 2023-08-21 |
| Metformin and Esomeprazole For Preterm Pre-eclampsia Esomeprazole 20mg - Preeclampsia Severe, Preeclampsia Second Trimester | Phase 1 | Unknown | Christiana Care Health Services | 38 | 2023-03-01 | 2023-02-10 |
| A Study of IBI351 in Healthy Subjects IBI351, Esomeprazole - Healthy Subjects | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 24 | 2023-02-16 | 2023-10-24 |
| Drug-drug Interaction Study of XZP-3621 Tablet XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin capsules (For Arm 2), XZP-3621 tablet and esomeprazole tablet (For Arm3) - Healthy Subjects | Phase 1 | Unknown | Xuanzhu Biopharmaceutical Co., Ltd. | 72 | 2022-11-15 | 2022-10-19 |
| A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood BI 1819479, Esomeprazole - Healthy | Phase 1 | Completed | Boehringer Ingelheim | 15 | 2022-10-18 | 2023-01-26 |
Showing 20 of 88. Sign in to see all of them.
Gastroesophageal Reflux (9) · Peptic Ulcer (4) · Dyspepsia (2) · Achlorhydria (1) · Arthritis (1) · Arthritis, Juvenile (1) · Asthma (1) · Autism Spectrum Disorder (1) · Barrett Esophagus (1) · Breast Neoplasms (1) · Esophagitis (1) · Esophagitis, Peptic (1) · Fasting (1) · Gastritis (1) · Gastrointestinal Diseases (1)
AstraZeneca (13) · Takeda (6) · HK inno.N Corporation (4) · Boehringer Ingelheim (3) · Millennium Pharmaceuticals, Inc. (3) · Pfizer (3) · Torrent Pharmaceuticals Limited (3) · Yuhan Corporation (3) · Bayer (2) · Eli Lilly and Company (2) · Hoffmann-La Roche (2) · Incyte Corporation (2) · Seoul National University Hospital (2) · Yooyoung Pharmaceutical Co., Ltd. (2) · Addpharma Inc. (1)
United States (37) · South Korea (17) · China (6) · Canada (5) · Germany (3) · Japan (3) · Australia (2) · Belgium (2) · Egypt (2) · Netherlands (2) · Sweden (2) · United Kingdom (2) · Finland (1) · Hungary (1) · Spain (1)
Lynne Durborow (2) · SeungHwan Lee, MD, PhD (2) · Tore Lind (2) · Ahmed Elshafeey, Ph.D. Pharma (1) · Aziz Laurent, MD (1) · Bo Fransson (1) · Choon Ok Kim, MD (1) · Christopher Billings ., D.O (1)
PMID 27875488, PMID 21171670, PMID 22464259, PMID 22631032, PMID 22832034, PMID 23333143, PMID 24677117, PMID 28052855, PMID 30445008, PMID 31564831, PMID 32274381, PMID 33062627, PMID 34621707, PMID 34825782, PMID 35218604, PMID 35281316, PMID 36409435, PMID 36897544, PMID 39803609, PMID 41120363, PMID 41348226, PMID 41920422
2023 (2), 2014 (1), 2017 (1)